Interleukin 2-Based Fusion Proteins for the Treatment of Cancer is a research paper published in Journal of Immunology Research (2021). On theSindex it has a DataRank of 0.564. It has been cited 42 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.564
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Cancer Institute
Grant: P50CA098252
National Cancer Institute
Grant: R01CA237067
National Institutes of Health
Grant: 5P50CA098252-17
SPORE in Cervical Cancer
National Institutes of Health
Grant: 5R01CA237067-05
Development of Novel Spontaneous HPV Cervicovaginal Carcinoma Models for Cancer Immunotherapy
FWCI
2.27
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals